US 5,326,754 AGranted

Antitumor antibiotic BMY-41219

AssigneeBristol-Myers Squibb Company

InventorsKin S. Lam, Leonard A. McDonald, Jacqueline Mattei, Salvatore Forenza, James A. Matson

Life of this patent

Estimating the term…

Abstract

An antitumor antibiotic designated BMY-41219 is produced by fermentation of Saccharothrix aerocolonigenes ATCC 39243. The BMY-41219 antibiotic exhibits antitumor activity.

Claims1

Dependent claims

A pharmaceutical composition for treating P388 leukemia comprising a tumor-inhibiting amount of the compound having the formula ##STR5## in combination with a pharmaceutical carrier.

Dependencies are inferred from the claim text.

Facts

Application: 08/063,383Filed 18 May 1993 · continuation
Priority: 6 Mar 1990
Granted: 5 Jul 1994
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof
C07H 19/044
Heterocyclic radicals containing only nitrogen atoms as ring hetero atom: pyrrole radicals
A61K
Medicines and medical preparations
C07H
Sugars

Family

Serial489,431Parent of this continuation · filed 6 Mar 1990
Serial764,114Parent of this continuation · filed 23 Sep 1991
Serial830,969Parent of this continuation · filed 6 Feb 1992
US 5,326,754 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…